
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series


HMO profits from Minnesota state programs jump to $675.8M with enrollment surge
Enrollees used less care than expected, and a state program to cap profits was no longer in place, leading to an increase of about 181% in operating income.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.